Northwestern University and Access Community Health Network Medication Education Study (NAMES)
Hypertension

About this trial
This is an interventional prevention trial for Hypertension focused on measuring Medication Therapy Management, Hypertension, Health Literacy, Medication Reconciliation, Medication Adherence
Eligibility Criteria
Inclusion Criteria:
- age is 18 years or older
- at least 3 medications are prescribed by their physician
- standardized mean blood pressure measurement ≥130 mm Hg systolic or ≥ 80 mm Hg diastolic if they are diabetic or mean blood pressure measurement ≥ 135 mm Hg systolic or ≥ 85 mm Hg diastolic if they are not
- a Mini-Cog Exam score of ≥ 3
- the patient is the person primarily responsible for administering their medication
- the patient does not intend to move or change their usual source of medical care during the next year.
Exclusion Criteria:
- the patient's usual source of medical care is not a participating ACCESS Community Health Center
- is non-English language speaking
- does not meet mean blood pressure criteria
- has a Mini-Cog Exam score of < 3
- is not the person primarily responsible for administering medication
- intends to move or change their usual source of medical care during the next year.
- Is not prescribed at least 3 medications
Sites / Locations
- ACCESS Community Health Network
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Standard Care
EHMI
Nurse Educator + EHMI
This arm will serve as a control group and will not receive any intervention.
Electronic Health Record-based Health Literacy Medication Therapy Management Intervention (EHMI)arm consists of multiple components, all leveraged by the Epic EHR platform (Verona, WI). The EHMI intervention 1) activates patients to review their medication list and identify any adherence-related concerns, 2) automates a process for providing plain language, patient-centered print medication information for new and refilled prescriptions, and 3) provides additional print tools to help patients more effectively engage their providers, consolidate their regimen, and generally promote safe use and adherence.